Introduction

Chloride (Cl
] i is much higher than would be expected [14] . [Cl − ] i ranging from~30 to~50 mM has been recorded in SMCs using a variety of techniques, including radioisotopes, fluorescent dyes, and ion-selective electrodes (see [57] ) is between −30 and −20 mV in SMCs [57, 66] . Physiological membrane potential (E m ) in vascular and nonvascular SMCs ranges between~−60 and~−40 mV [6, 44, 83, 85, 86, 118] . Cl − channel activation would result in Cl − efflux, leading to membrane depolarization, voltage-dependent calcium (Ca 2+ ) channel activation, an elevation in [Ca activated Cl − currents in rabbit pulmonary artery SMCs [59, 121, 123] .
Research using a variety of nonselective Cl − channel antagonists further supported the concept that Cl − flux contributes to vasoconstriction. 4,4′-Diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) and indaryloxyacetic acid (IAA-94), but not niflumic acid (NFA), hyperpolarized and relaxed pressurized rat cerebral arteries [84] . NFA reduced NE-but not K + -induced contractions in rat aorta and mesenteric arteries [16, 17, 62] . Histamine-induced depolarization and contraction were also attenuated by NFA in rabbit middle cerebral and basilar arteries, respectively [37, 120] . IAA-94 inhibited ET-induced vasoconstriction in cultured vascular SMCs [114] . Anion replacement has also been utilized to strengthen functional evidence obtained using nonspecific Cl − channel inhibitors. Substitution of extracellular Cl − with methanesulfonate potentiated NE-, serotonin-, endothelin-1-, and histamineinduced, but not K + -induced contractions in rabbit basilar arteries and rat aorta [19, 20, 62] . Lowering extracellular Cl − potentiated pressure-induced constriction and inhibited histamine-induced contraction in rat cerebral arteries [84, 120] . Substitution with Br − and NO 3 − , which are more permeant anions than Cl − , increased contraction to NE in rat portal vein [125] .
In addition to modulating SMC contractility, both volumesensitive Cl − channels and Ca
2+
-activated Cl − channels (Cl Ca ) channels have been proposed to control SMC proliferation [12, 138, 142] . DIDS, but not IAA-94 or 5-nitro-2,2″-dicarboxylic acid (NPPB), another nonselective Cl − channel blocker, suppressed ET-1-induced proliferation in cultured aortic SMCs [138] . In contrast, NPPB and IAA-94, but not DIDS, inhibited insulin-like growth factor (IGF)-induced proliferation in porcine coronary artery SMCs [12] . Under chronic hypoxic conditions, NFA and IAA-94 also inhibited proliferation of rat pulmonary artery SMCs [142] . In summary, studies measuring ion flux and those using nonselective Cl − channel blockers and extracellular anion Predicted membrane topologies of Cl − channels described in vascular SMCs. TMEM16A/ANO1 was adapted from [144] , although an alternative membrane topology has been suggested [144] . Bestrophin modified from ref. [79] , ClC-3 from ref.
[27], and CFTR from ref. [152] modulate SMC functions were demonstrated to inhibit wholecell Cl Ca currents, supporting relevance [64] [9, [64] [65] [66] . Some of these regulatory mechanisms appear to be cell type-specific, as blockers of nonselective cation channels but not VDCCs inhibited Cl Ca currents in cerebral artery SMCs [9] . In contrast, Ca 2+ entry through VDCCs activated Cl Ca currents in rat portal vein and rabbit coronary artery SMCs [64, 92] . Extracellular Ca 2+ removal had no immediate effect on Cl Ca currents in pig aorta and rabbit ear artery and portal vein SMCs, suggesting that external Ca 2+ was not a primary direct source for activation [2, 26, 129] Bestrophins, CLCs, CLCAs, and a tweety-3 homolog have been proposed to generate Cl Ca currents [66] . Tweety appeared to be an unlikely candidate due to its relatively high conductance [113] . Similarly, recombinant CLCA channels generate currents that were kinetically distinct from Cl Ca currents in SMCs [66] . The voltage dependence of recombinant bestrophins or CLCs was also dissimilar to those of SMC Cl Ca currents [45, 87, 111] . Recently discovered TMEM16A/ ANO1 channels displayed properties similar to native Cl Ca channels [10, 105, 141] . TMEM16A/ANO1 channel message and protein have been described in rat cerebral, pulmonary and carotid artery, murine portal vein, and cultured rat pulmonary artery SMCs [21, 72, 117] . Evidence supporting the contribution of TMEM16A/ANO1 channels to Cl Ca currents includes the fact that recombinant channels and native SMC Cl Ca currents exhibit similar Ca 2+ dependence and IV linearization by an elevation in [Ca 2+ ] i (Fig. 2) [10, 72, 82, 106, 117] . TMEM16A/ANO1 knockdown reduced Cl Ca current density in rat cerebral artery and cultured pulmonary artery SMCs [72, 117] . Cell swelling and membrane stretch activated TMEM16A/ANO1 currents in cerebral artery SMCs [9] . Selective TMEM16A/ANO1 knockdown attenuated intravascular pressure-induced cerebral artery depolarization and vasoconstriction [9] . T16A inh -A01, a TMEM16A/ANO1 inhibitor, relaxed methoxamine-contracted murine and human blood vessels, suggesting that agonists can activate these ion channels to induce contraction [22] . These studies provide strong evidence that TMEM16A/ANO1 channels generate classic Cl Ca currents in SMCs.
TMEM16A/ANO1 channels also appear to generate functional Cl Ca currents in nonvascular SMCs. TMEM16A/ANO1 is expressed in sheep, rat, and mice urethral SMCs [103] . Electronic field stimulation (EFS)-and NE-induced uterine contractions were inhibited by NFA and exposure to Cl − -free Krebs solution [103] . The authors suggested that TMEM16A/ ANO1 regulates the development and maintenance of excitatory contractile responses in urethral SMCs [103] . TMEM16A/ANO1 is expressed in airway SMCs, and activation contributes to methacholine-induced contraction [146] . Benzbromarone, a TMEM16A/ANO1 blocker, inhibited methacholine-induced contraction of mouse and human airway SMCs [50] . TMEM16A/ANO1 is also expressed in interstitial cells of Cajal (ICC), which control SMC contraction and induce rhythmic slow waves in the gastrointestinal tract [38, 49, 52, 104] . In TMEM16A knockout mice, rhythmic contractions are reduced or absent in gastric and small intestine SMCs [49, 52] .
Recent studies suggest that alterations in TMEM16A/ANO1 function contribute to cardiovascular pathology. Cl Ca currents were elevated in pulmonary artery SMCs of rats exposed to hypoxia for 7 days [70] . TMEM16A/ANO1 mRNA/protein and Cl Ca currents were elevated in pulmonary artery SMCs of rats with chronic hypoxic pulmonary hypertension (CHPH) [112] . Cl Ca currents and TMEM16A/ANO1 expression were also increased in conduit and intralobar pulmonary artery SMCs from monocrotaline (MCT)-treated rats, another pulmonary hypertension model [32] . NFA and T16A inh -A01 both attenuated an elevation in serotonin-induced vasocontraction in pulmonary arteries from both CHPH and MCT rats [32, 112] . In contrast, TMEM16A/ANO1 protein and Cl Ca currents were both lower in basilar artery SMCs isolated from 2-kidney, 2-clip renohypertensive (2k2c)-rats [133] . The authors concluded that TMEM16A/ANO1 is a negative regulator of cell proliferation and may be important in hypertension-induced cerebrovascular remodeling.
In an ovalbumin (OVA)-sensitized mouse model of chronic asthma, TMEM16A/ANO1 expression was higher, suggesting contribution to airway hyperresponsiveness [146] . NFA and benzbromarone prevented airway hyperresponsiveness and augmented airway SMC contraction. Agonist-mediated contraction was also attenuated in airway SMCs of TMEM16A/ANO1 −/− mice [146] . An increase in TMEM16A protein expression and Cl Ca channel activity was observed in asthmatic mouse models and human asthmatic patients, although this increase in protein was primarily observed in epithelial, not smooth muscle, cells [50] . In summary, studies suggest that TMEM16A/ANO1 channels generate Cl Ca currents, and activation leads to membrane depolarization and constriction in both vascular and nonvascular SMCs. Diseases are associated with altered TMEM16A/ANO1 expression and functionality, with differential changes described that may depend on multiple factors, including the pathology involved.
cGMP-dependent Cl Ca channels A Cl Ca current distinct from classic Cl Ca that requires cGMP for Ca 2+ activation was initially discovered in rat mesenteric artery SMCs [93] . Subsequently, this current has been described in multiple vascular and colonic SMCs [55, 73, 74] . cGMPdependent Cl Ca currents are voltage-independent and require lower [Ca 2+ ] i for activation than classic Cl Ca currents [74, 94] . Halide permeability is also different to classic Cl Ca currents, at Br [74, 94] . cGMP-dependent Cl Ca currents are highly sensitive to Zn 2+ and relatively insensitive to both NFA and DIDS, effective classic Cl Ca blockers [73] . cGMPdependent and classic Cl Ca current densities are approximately equal in SMCs from many vascular beds, although deviations from this stereotype have been described [74] .
cGMP-dependent Cl Ca currents should induce membrane depolarization and vasoconstriction. Such an effect is counterintuitive to the recognized actions of cGMP-mediated PKG activation, which activates several K + channels, including BK Ca , leading to membrane hyperpolarization and relaxation [73, 116] . Conceivably, cGMP-dependent Cl Ca currents act as a break to oppose the cGMP-mediated vasodilation, permitting an additional level of fine tuning of membrane potential and contractility.
The molecular identity of cGMP-dependent Cl − channels is unclear, but bestrophins, a family of four proteins (1 through 4), can control this current. Cl − currents generated by recombinant bestrophins are Ca 2+ -activated, but do not resemble those of classical Cl Ca (Fig. 3) [4, 13, 97, 111] . Bestrophin-3 mRNA and protein are present in rat mesenteric arteries, rat aorta, and cultured A7r5 cells [75] . In contrast, bestrophin-1 and bestrophin-2 are weakly expressed in these tissues [75] . In line with these observations, studies have focused primarily on identifying physiological functions of bestrophin-3 in SMCs [8] . Bestrophin-3 is found in rabbit, but not rat, pulmonary arteries suggesting species-specific expression [66] . The presence of bestrophin protein has been described to match that of cGMP-dependent Cl Ca currents in SMCs. Bestrophin-3 knockdown reduced cGMP-dependent Cl Ca currents in cultured A7r5 cells and rat mesenteric artery SMCs, but did not alter classic Cl Ca currents [75] . Vasomotion in rat mesenteric arteries was reported to have a strong Cl − dependency that required cGMP [5, 93] . Replacement of extracellular Cl − with less permeable aspartate inhibited vasomotion in rat mesenteric arteries [5] . Consistent with a role for bestrophins, bestrophin-3 knockdown reduced synchronized vasomotion, but not tonic contractility, in rat mesenteric arteries [8] . Cl Ca current has not been uniformly observed after bestrophin-3 expression in heterologous expression systems; therefore, it is unclear whether the protein forms a prototypical ion channel or is an accessory subunit [88, 96] . In addition to regulating vasomotion, bestrophin-3 has been demonstrated to inhibit H 2 O 2 -induced apoptosis in basilar artery SMCs [55] . Bestrophin-3 knockdown reduced cell viability, whereas bestrophin-3 overexpression prevented apoptosis. Supporting a protective role, bestrophin-3 overexpression reduced ER stress-induced cell death in cultured renal epithelial cells [67] .
In summary, both cGMP-dependent and cGMP-independent Cl Ca currents have been observed in vascular SMCs [74] . Data indicate that two distinct Cl Ca channels generate these currents, including that bestrophin-3 tissue distribution closely matches that of cGMP-dependent Cl Ca currents [75] . The majority of research on bestrophins in SMCs has been in mesenteric arteries. Future studies should investigate bestrophin functions in other vascular beds and whether bestrophins form a prototypical ion channel or an accessory subunit to another ion channel protein. Although bestrophin-3 locates near the cell surface in mesenteric artery SMCs, other bestrophin family members (bestrophin-1 and bestrophin-2) are intracellular proteins when expressed in heterologous expression systems [8, 61, 97] . Conceivably, in SMCs of different vascular beds, other bestrophin proteins may be expressed and perform additional physiological functions. (Fig. 4) [54]. Currently, ClC-3 is the only molecular candidate for a volume-sensitive Cl − channel in SMCs. Therefore, evidence supporting ClC-3 will be summarized in this section.
ClC-3 message was detected in canine pulmonary and renal artery SMCs [140] . ] i of 500 nM [88] . Adapted with permission from ref. [88] . © the American Physiological Society (APS). Whole-cell niflumic acid (NFA)-insensitive cGMP-dependent Cl Ca current recorded in a mesenteric artery SMC [5] . Adapted with kind permission from Springer Science+Business Media: (ref. [5] , Fig. 7) to compensatory upregulation of other volume-regulated ion channels [139] . Consistent with this concept, mRNA for ClC-1 and ClC-2, but not ClC-4 or ClC-5, is elevated in Clcn3 −/− mice atrial myocytes [139] .
Volume-regulated Cl − channels may depend on an association between ClC-3 and NADPH oxidase(Nox)-dependent reactive oxygen species (ROS) signaling in SMCs [76] . ClC-3 locates to membrane of organelles, including endosomes, where it regulates Nox1-mediated ROS generation [43, 80] .
ClC-3 acts as a Cl
− /H + exchanger that neutralizes electron flow generated by Nox1 [80] . SMCs from ClC-3 −/− mice did not generate endosomal ROS or activate transcription factor nuclear factor (NF)-κB in response to tumor necrosis factor (TNF)-α and interleukin (IL)-1β [80] . As a result, volumeregulated Cl − current was not activated by TNF-α and IL-1β in ClC-3 −/− mice [76] .
Evidence has been provided that ClC channels control SMC function. In pig artery SMCs, ClC-2 knockdown suppressed IGF-1-induced proliferation [12] . ClC-3 knockdown inhibited endothelin-1 (ET-1)-induced aortic SMC proliferation by arresting the cell cycle [115, 131] . Aortic SMCs from Clcn3 −/− mice proliferated more slowly than those from wild-type controls [80] . TNF-α and carotid artery injury both stimulated ClC-3 expression with injury-induced carotid artery neointima formation reduced in Clcn3 −/− mice [15] . ClC-3 overexpression inhibited apoptosis in pulmonary artery SMCs [18] . ClC-3 is associated with changes in SMC function during disease. A hypotonicity-induced decrease in [Cl − ] i and an increase in rat basilar artery SMC size correlated with hypertension in 2k2c rats, suggesting that volume-sensitive Cl − channels are more active and may be involved in vascular remodeling [107] . ClC-3 mRNA and protein were both elevated in pulmonary artery SMCs of rats with experimentally induced pulmonary hypertension [18] . Static pressure stimulated ClC-3 expression, volume-sensitive Cl − currents, and proliferation in aortic SMCs, and these changes were attenuated by Cl − channel blockers and ClC-3 knockdown [95] . [3, 76] . However, ClC-3 is expressed in SMCs and both knockdown and knockout result in physiological changes [140] . ClC-3 expression levels are also altered in disease states. Further studies are required to determine SMC CLC-3 cellular localization and whether ClC-3 is a Cl − channel or an accessory protein.
CFTR
The cystic fibrosis transmembrane conductance regulator (CFTR), a cAMP-activated ATP-gated anion channel, has primarily been studied in epithelial cells, where it was originally identified [98] . CFTR channels have subsequently been found in a number of other cell types, including neurons, cardiac myocytes, and endothelial cells [35, 119, 136] . CFTR functions in SMCs were initially proposed from experiments using highly nonspecific pharmacological modulators [23, 68, 147] . Subsequent studies using immunofluorescence and Western blotting demonstrated CFTR expression in rat thoracic aorta and intrapulmonary artery [101, 102] . cAMP pathway and CFTR activators both activated iodide efflux in cultured vascular SMCs and relaxed precontracted, depolarized endothelium-denuded aortic and intrapulmonary artery rings via a mechanism sensitive to CFTR inh -172, a more selective CFTR blocker [100, 102] . cAMP pathway agonists [100] . These studies suggested that stimulation of the cAMP pathway and CFTR activation were functional when the SMC membrane potential was more positive than the E Cl . Under this condition, CFTR channel activation appears to oppose vasoconstriction. A study demonstrating that myogenic tone is enhanced in both CFTR −/− cerebral and mesenteric arteries supports the concept that CFTR activation hyperpolarizes membrane potential [77] .
CFTR is also expressed in nonvascular SMCs [78, 122] . cAMP pathway agonists and CFTR activators stimulated iodide efflux and induced CFTR inh -172-sensitive relaxation of tracheal SMCs [122] . CFTR knockdown attenuated histamineinduced intracellular Ca 2+ release in airway SMCs [78] . CFTR −/− mice also exhibit ileal SMC phenotypes that vary when studied on different mouse strains [99] . Furthermore, CFTR channel knockout results in small intestine circular smooth muscle dysfunction 7 days postnatal in mice [24] .
SMC dysfunction, including bronchoconstriction, airway hyperresponsiveness, gastric dysmotility, and intestinal obstruction, may contribute to the cystic fibrosis disease phenotype [78] . Thus, CFTR modulators may have therapeutic benefit by acting on airway SMCs. Conceivably, CFTR activators may also have antihypertensive actions, although many questions still remain regarding function in SMCs. CFTR knockout may induce many different compensatory mechanisms that could modify contractility. Conceivably, CFTR may regulate other Cl − channels in vascular SMCs. CFTR expression inhibits both volume-sensitive Cl − and Cl Ca current in bovine pulmonary artery endothelial cells, and upregulation of its expression results in a corresponding downregulation in both channels in recombinant cells [60, 123, 134] . Whether similar regulating mechanisms exist in SMCs is unclear, but possible. Importantly, CFTR channels have not been directly measured in SMCs using electrophysiological techniques, including patch-clamp electrophysiology. Similarly, SMC-specific inducible CFTR −/− knockout mice should be studied and systemic blood pressure measurements performed. Such data -HO 3 − exchanger-2 (AE2). cGMP-dependent and independent Cl Ca channels, a volume-sensitive Cl − channel, and the cystic fibrosis transmembrane conductance regulator (CFTR) have been identified. The molecular identity of the first three channels has been proposed to be bestrophin, TMEM16A/Ano1, and ClC-3, respectively. Numerous mechanisms of Ca 2+ activation of Cl Ca channels in vascular SMCs have been suggested, including IP 3 R-or RyR-mediated SR Ca 2+ release, Ca 2+ entry through voltage-dependent Ca 2+ channels (VDCC), and local Ca 2+ influx through nonselective cation channels (NSCC). Activation of these channels leads to Cl − efflux and subsequent depolarization of the cell membrane that activates voltage-dependent Ca 2+ channels (VDCC). ClC-3 channels have been proposed to be activated by membrane swelling. ClC-3 is present in the plasma membrane and in intracellular compartments, including endosomes. Endosomal ClC-3 channels may regulate volume-regulated Cl − channels via ROS production. CaMKII inhibits TMEM16A and activates ClC-3 channels. CFTR is a cAMP-activated ATP-gated anion channel that appears to be functional when the SMC membrane potential becomes more positive than the Cl − equilibrium potential. Under this condition, CFTR channel activation would lead to Cl − influx and oppose vasoconstriction would provide stronger support for physiological functions of vascular SMC CFTR.
Conclusions
Research has focused primarily on discovering the molecular identity, physiological functions, and pathological significance of cation channels expressed in SMCs. In contrast, little is known of anion channels, specifically Cl − channels that are expressed in SMCs. This knowledge gap has arisen, in part, due to a lack of specific Cl − channel modulators and uncertain molecular identity of the proteins present. Recent discoveries of TMEM16A/ANO1, bestrophin, ClC-3, and CFTR expression in SMCs have provided new insights (Fig. 5) . Identification of these proteins has permitted the use of molecular biology techniques to inhibit Cl − channel expression and study the effects on SMC function. Evidence suggests that multiple Cl − channel types are expressed in SMCs. These channels can control physiological functions, including contractility and proliferation, and can contribute to SMC pathologies.
Future directions
Future studies should aim to identify intracellular signaling pathways that regulate different Cl − channels in SMCs and downstream functional effects of such modulation. Many ion channels have one or more auxiliary and regulatory subunits, and these proteins can, in some cases, exhibit SMC-specific expression (e.g., K Ca channel β1 subunits [7] ). It is possible that Cl − channels have auxiliary subunits, although this remains to be determined. Similarly, whether some proteins identified are pore-forming Cl − channels or accessory subunits is unclear, including some bestrophins and ClC proteins. Similarly, different Cl − channels may interact and regulate each other directly, for example through heteromultimer formation, and indirectly, via signaling networks. Many of these research directions will benefit from the discovery of specific Cl − channel modulators and animals with inducible, SMC- 
